Bionas Inks First Large Contract Research Deal with Solvay; May Lead to 2500 Purchase | GenomeWeb
Building on an existing agreement with Solvay Pharmaceuticals, Bionas this week said that it has entered into its first large-scale service contract with the company’s site in Hannover, Germany.
Under the terms of the agreement, Bionas will use its Bionas 2500 high-content analysis instrument to profile and rank at least two compounds that the Solvay group identified in the context of its obesity research program. Financial details were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.